rs17248720

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The variant allele was found at a frequency of 0.162 in 151,590 control chromosomes in the GnomAD database, including 2,419 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.16 ( 2419 hom., cov: 30)

Consequence

Unknown

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.103

Publications

24 publications found
Variant links:

Genome browser will be placed here

ACMG classification

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 19-11087511-C-T is Benign according to our data. Variant chr19-11087511-C-T is described in ClinVar as Benign. ClinVar VariationId is 684564.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.267 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt

Frequencies

GnomAD3 genomes
AF:
0.162
AC:
24559
AN:
151494
Hom.:
2414
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.271
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.158
Gnomad ASJ
AF:
0.134
Gnomad EAS
AF:
0.0490
Gnomad SAS
AF:
0.167
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.159
Gnomad NFE
AF:
0.115
Gnomad OTH
AF:
0.149
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.162
AC:
24585
AN:
151590
Hom.:
2419
Cov.:
30
AF XY:
0.164
AC XY:
12119
AN XY:
74042
show subpopulations
African (AFR)
AF:
0.271
AC:
11211
AN:
41294
American (AMR)
AF:
0.158
AC:
2395
AN:
15176
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
463
AN:
3468
East Asian (EAS)
AF:
0.0493
AC:
254
AN:
5152
South Asian (SAS)
AF:
0.165
AC:
792
AN:
4800
European-Finnish (FIN)
AF:
0.115
AC:
1207
AN:
10476
Middle Eastern (MID)
AF:
0.161
AC:
47
AN:
292
European-Non Finnish (NFE)
AF:
0.115
AC:
7790
AN:
67920
Other (OTH)
AF:
0.148
AC:
310
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
995
1990
2984
3979
4974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.129
Hom.:
286
Bravo
AF:
0.172
Asia WGS
AF:
0.143
AC:
501
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Benign:1
Jul 16, 2018
Department of Human Genetics, Laborarztpraxis Dres. Walther, Weindel und Kollegen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Due to the increased occurrence of the mutation (>= 5%), this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
1.3
DANN
Benign
0.73
PhyloP100
-0.10

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17248720; hg19: chr19-11198187; API